reference/20083624

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20083624

Outgoing Links

Predicate	Object
contentType	Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	141
issn	0049-3848
issueIdentifier	2
pageRange	137-141
publicationName	Thrombosis Research
startingPage	137
bibliographicCitation	Ageno W, Cattaneo R, Manfredi E, Chelazzi P, Venco L, Ghirarduzzi A, Cimino L, Filippucci E, Ricci AL, Romanelli D, Incorvaia C, D'Angelo S, Campana F, Molfino F, Scannapieco G, Rubbi F, Imberti D. Parnaparin versus aspirin in the treatment of retinal vein occlusion. A randomized, double blind, controlled study. Thromb Res. 2010 Feb;125(2):137–41. doi: 10.1016/j.thromres.2009.05.007. PMID: 19477488.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1922-8879 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b7c976c675dadef3ab899e61fa140183 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f358adf272d7ebf6e619faea670070c4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7956-9950 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0d3927107673adf99e33d9d756c7fc05 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_659b3906413fb0aa8e916ae27194c03b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dc68295959f6952cf18227e6f5594a5d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ae0787a1eed47dac36400125201fd10e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1f5de823d43f5f20177254b8eb4f606c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3acffea7220ccfc46774d2e35e11964d http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1118-3845 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c37c92de5ab6bbf2be3294a3b7027df4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e40b47ad5622c1511012f3e89ee4b715 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_50e7c84bdea5d8806e69b5fbb29f50a5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_00406a8fb1c30d65c822d560ef4b9170 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_94aa039a5a92f0eab85a9dfc5b63ec85 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_13337ce48dac163fa49dd090b995275e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_582ec68142fe47c0f262025e1701c3e8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bc68cc07fe19870fa89275e40706e59b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4f39b24077d3a3d00bb974d5f6e91cc0
date	201002
identifier	https://pubmed.ncbi.nlm.nih.gov/19477488 https://doi.org/10.1016/j.thromres.2009.05.007
isPartOf	https://portal.issn.org/resource/ISSN/0049-3848 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/7735
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Parnaparin versus aspirin in the treatment of retinal vein occlusion. A randomized, double blind, controlled study
discusses	http://id.nlm.nih.gov/mesh/M0008434 http://id.nlm.nih.gov/mesh/M0216081 http://id.nlm.nih.gov/mesh/M0010191 http://id.nlm.nih.gov/mesh/M0017012 http://id.nlm.nih.gov/mesh/M0001864
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D010975Q000627 http://id.nlm.nih.gov/mesh/D001241Q000627 http://id.nlm.nih.gov/mesh/D006495Q000627 http://id.nlm.nih.gov/mesh/D005343Q000627 http://id.nlm.nih.gov/mesh/D012170Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D001241Q000009 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D010979 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D006495Q000009 http://id.nlm.nih.gov/mesh/D006470 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D004334
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9091 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7062 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID772 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16850 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID638015

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127563695 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128684338 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127977452

Total number of triples: 69.